Figures and Tables

From the following article:

Aromatase inhibitors for breast cancer: lessons from the laboratory

Stephen R.D. Johnston & Mitch Dowsett

Nature Reviews Cancer 3, 821-831 (November 2003)

doi:10.1038/nrc1211

Figure 1 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 1

Mechanism of action of aromatase inhibitors and tamoxifen.

Figure 2 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 2

Molecular effects of tamoxifen and oestrogen deprivation on oestrogen receptor.

Figure 3 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 3

Endocrine treatment of xenografts.

Figure 4 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 4

Control of aromatase expression in breast carcinomas.

Figure 5 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 5

Molecular structures of aromatase inhibitors in clinical use.

Figure 6 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 6

Side effects of anastrozole compared with tamoxifen.

Figure 7 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Figure 7

Signalling pathways between cell-surface growth-factor receptors and nuclear oestrogen receptor.

Table 1 - Aromatase inhibitors for breast cancer: lessons from the laboratory

Table 1

Trials of third-generation aromatase inhibitors in advanced breast cancer